Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants

Early Human Development

Volumn 88, Issue SUPPL. 1, 2012, Pages

  Dani, Carlo ^a   Corsini, Iuri ^b   Poggi, Chiara ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Failure; INSURE; NCPAP; Preterm infant; Surfactant

Indexed keywords

PORACTANT;

ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BODY WEIGHT; DRUG TREATMENT FAILURE; EXTUBATION; GESTATIONAL AGE; HUMAN; INFANT; INTUBATION; INTUBATION SURFACTANT EXTUBATION METHOD; MAJOR CLINICAL STUDY; PREMATURITY; RISK FACTOR;

AIRWAY EXTUBATION; BLOOD GAS ANALYSIS; BODY WEIGHT; COHORT STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTUBATION; OXYGEN; PULMONARY SURFACTANTS; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

EID: 84858076122     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.12.019     Document Type: Article

References (20)

1. Ho J.J., Henderson-Smart D.J., Davis P.G. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002, CD002975.
2. Henderson-Smart D.J., Wilkinson A., Raynes-Greenow C.H. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev 2002, CD002770.
3. Attar M.A., Donn S.M. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol 2002, 7:353-360.
4. Dani C., Bertini G., Pezzati M., Cecchi A., Caviglioli C., Rubaltelli F.F. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004, 113:e560-e563.
5. Dani C., Corsini I., Bertini G., Fontanelli G., Pratesi S., Rubaltelli F.F. The INSURE method in preterm infants of less than 30 weeks' gestation. J Matern Fetal Neonatal Med 2010, 23:1024-1029.
6. Reininger A., Khalak R., Kendig J.W., Ryan R.M., Stevens T.P., Reubens L., et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005, 25:703-708.
7. Sandri F., Plavka R., Ancora G., Simeoni U., Stranak Z., Martinelli S., et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010, 125:e1402-e1409.
8. Andersen T., Holm H.S., Kamper J. Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment. Ugeskr Laeger 2006, 23(168):3723-3727.
9. Cherif A., Hachani C., Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Perinatol 2008, 25:647-652.
10. Rojas M.A., Lozano J.M., Rojas M.X., Laughon M., Bose C.L., Rondon M.A., et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized controlled trial. Pediatrics 2009, 123:137-142.
11. Gutbrod T., Wolke D., Soehne B., Ohrt B., Riegel K. Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison. Arch Dis Child Fetal Neonatal Ed 2000, 82:F208-F214.
12. Torrance H.L., Mulder E.J., Brouwers H.A., Van Bel F., Visser G.H. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Matern Fetal Neonatal Med 2007, 20:613-621.
13. Bohlin K., Gudmundsdottir T., Katz-Salamon M., Jonsson B., Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007, 27:422-427.
14. Dani C., Corsini I., Bertini G., Pratesi S., Barp J., Rubaltelli F.F. Effect of multiple INSURE procedures in extremely preterm infants. J Matern Fetal Neonatal Med 2011, 24:1427-1431.
15. Diemel R.V., Walch M., Haagsman H.P., Putz G. In vitro and in vivo intrapulmonary distribution of fluorescently labeled surfactant. Crit Care Med 2002, 30:1083-1090.
16. Goldsmith L.S., Greenspan J.S., Rubenstein S.D., Wolfson M.R., Shaffer T.H. Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention. J Pediatr 1991, 119:424-428.
17. Cotton R.B., Olsson T., Law A.B., Parker R.A., Lindstrom D.P., Silberberg A.R., et al. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res 1993, 34:495-501.
18. Frerichs I., Dargaville P.A., van Genderingen H., Morel D.R., Rimensberger P.C. Lung volume recruitment after surfactant administration modifies spatial distribution of ventilation. Am J Respir Crit Care Med 2006, 174:772-779.
19. Krause M.F., Jakel C., Haberstroh J., Schulte-Monting J., Leititis J.U., Orlowska-Volk M. Alveolar recruitment promotes homogeneous surfactant distribution in a piglet model of lung injury. Pediatr Res 2001, 50:34-43.
20. Hallman M., Merritt T.A., Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin Pharmacokinet 1994, 26:215-232.